The Food and Drug Administration (FDA) announced it is investigating reports of infections associated with reprocessed urological endoscopes. The FDA received more than 450 medical device reports (MDRs) describing post-procedure patient infections or other contamination issues associated with reprocessing urological endoscopes. Andersen’s EOGas 4 presents an FDA-cleared terminal sterilization option for the urological endoscopes under investigation, as well as significantly longer and smaller diameter scopes.